These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23956713)

  • 21. Implications of the use of neuromuscular transmission monitoring on immediate postoperative extubation in off-pump coronary artery bypass surgery.
    Cammu G; De Keersmaecker K; Casselman F; Coddens J; Hendrickx J; Van Praet E; Deloof T
    Eur J Anaesthesiol; 2003 Nov; 20(11):884-90. PubMed ID: 14649340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sugammadex antagonism of rocuronium-induced neuromuscular blockade in patients with liver cirrhosis undergoing liver resection: a randomized controlled study.
    Abdulatif M; Lotfy M; Mousa M; Afifi MH; Yassen K
    Minerva Anestesiol; 2018 Aug; 84(8):929-937. PubMed ID: 29405667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in the use of neuromuscular blocking agents, reversal agents and neuromuscular transmission monitoring: a single-centre retrospective cohort study.
    Krijtenburg P; de Boer A; Bash LD; Scheffer GJ; Keijzer C; Warlé MC
    Perioper Med (Lond); 2024 Mar; 13(1):22. PubMed ID: 38539254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current use of neuromuscular blocking agents and antagonists in Korea: a 2018 survey.
    Kim JS; Han JW; Lee JH; Choi JM; Kim HJ; Sung TY; Kim YB; Shin YS; Yang HS
    Anesth Pain Med (Seoul); 2019 Oct; 14(4):441-448. PubMed ID: 33329775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survey of postoperative residual curarization, acute respiratory events and approach of anesthesiologists.
    Aytac I; Postaci A; Aytac B; Sacan O; Alay GH; Celik B; Kahveci K; Dikmen B
    Braz J Anesthesiol; 2016; 66(1):55-62. PubMed ID: 26768931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of reversal with neostigmine of low-dose rocuronium vs. reversal with sugammadex of high-dose rocuronium for a short procedure.
    Choi ES; Oh AY; Koo BW; Hwang JW; Han JW; Seo KS; Ahn SH; Jeong WJ
    Anaesthesia; 2017 Oct; 72(10):1185-1190. PubMed ID: 28493510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of protocol and evaluation of postoperative residual curarization incidence in the absence of intraoperative acceleromyography - Randomized clinical trial].
    Santos FNC; Braga AFA; Ribeiro CJBL; Braga FSDS; Carvalho VH; Junqueira FEF
    Rev Bras Anestesiol; 2017; 67(6):592-599. PubMed ID: 28410818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK; Caldwell JE; Brull SJ; Soto RG
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
    Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
    J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between first-twitch depression and train-of-four ratio during sugammadex reversal of rocuronium-induced neuromuscular blockade.
    Kim KS; Oh YN; Kim TY; Oh SY; Sin YH
    Korean J Anesthesiol; 2016 Jun; 69(3):239-43. PubMed ID: 27274368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flucloxacillin and diclofenac do not cause recurrence of neuromuscular blockade after reversal with sugammadex.
    Kam PJ; Heuvel MW; Grobara P; Zwiers A; Jadoul JL; Clerck Ed; Ramael S; Peeters PA
    Clin Drug Investig; 2012 Mar; 32(3):203-12. PubMed ID: 22201295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recovery from neuromuscular block after an intubation dose of cisatracurium and rocuronium in lumbar disc surgery.
    Hans P; Welter P; Dewandre PY; Brichant JF; Bonhomme V
    Acta Anaesthesiol Belg; 2004; 55(2):129-33. PubMed ID: 15264506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex.
    de Boer HD; van Egmond J; Driessen JJ; Booij LH
    Rev Esp Anestesiol Reanim; 2010 Mar; 57(3):181-4. PubMed ID: 20422852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
    Carron M; Zarantonello F; Tellaroli P; Ori C
    J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sugammadex versus neostigmine for routine reversal of rocuronium block in adult patients: A cost analysis.
    Hurford WE; Welge JA; Eckman MH
    J Clin Anesth; 2020 Dec; 67():110027. PubMed ID: 32980763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of rocuronium-induced neuromuscular blockade by sugammadex allows for optimization of neural monitoring of the recurrent laryngeal nerve.
    Lu IC; Wu CW; Chang PY; Chen HY; Tseng KY; Randolph GW; Cheng KI; Chiang FY
    Laryngoscope; 2016 Apr; 126(4):1014-9. PubMed ID: 26748952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of rocuronium and sugammadex under neuromuscular transmission monitoring in a patient with multiple sclerosis.
    Staikou C; Rekatsina M
    Saudi J Anaesth; 2017; 11(4):472-475. PubMed ID: 29033729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007362. PubMed ID: 19821409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†,
    Kaufhold N; Schaller SJ; Stäuble CG; Baumüller E; Ulm K; Blobner M; Fink H
    Br J Anaesth; 2016 Feb; 116(2):233-40. PubMed ID: 26787792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.